Profil
Bradford C.
Sippy is the founder of Tremeau Pharmaceuticals, Inc. which he founded in 2016 and where he holds the title of Chief Executive Officer & Director.
He is currently the Chief Executive Officer & Director at Lennham Pharmaceuticals, Inc. where he is still actively employed.
Postes actifs de Bradford C. Sippy
| Sociétés | Poste | Début |
|---|---|---|
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Fondateur | 01/07/2016 |
Lennham Pharmaceuticals, Inc.
 Lennham Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lennham Pharmaceuticals, Inc. develops pharmaceutical products. The CEO of the American company is Bradford C. Sippy. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Tremeau Pharmaceuticals, Inc.
Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Health Technology |
Lennham Pharmaceuticals, Inc.
Lennham Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lennham Pharmaceuticals, Inc. develops pharmaceutical products. The CEO of the American company is Bradford C. Sippy. | Health Technology |
